Loading...
QUIK is not a good buy right now for an impatient investor. Price is trading below key support with weakening momentum, Wall Street’s latest view is a downgrade with a price target ($5.95) well below the current price ($7.675), and the latest quarter showed sharp revenue contraction and negative gross margin. With no proprietary buy signals today and downside-biased pattern probabilities over the next day/week/month, the risk/reward is unfavorable for an immediate entry.
Trend/price action: Despite a bullish longer-term moving-average stack (SMA_5 > SMA_20 > SMA_200), the near-term tape is weak: current price (7.675) is below S1 (7.824) and closer to S2 (7.44), implying a support break and poor immediate structure.
Momentum: MACD histogram is negative (-0.0606) and expanding lower, which supports continued downside momentum. RSI(6)=43.3 is neutral but leaning bearish (not oversold enough to suggest a high-conviction bounce for an impatient entry).
Levels: Resistance overhead is at the pivot 8.445, then 9.065. With price under S1, a quick reclaim of ~7.82 is needed just to stabilize; otherwise the next technical magnet is ~7.44.
Stat/pattern read-through: Similar candlestick-pattern analog suggests a downside bias: ~60% chance of -1.18% next day, -1.64% next week, -6.14% next month.
Intellectia Proprietary Trading Signals

on 2026-02-19 after hours could act as an event catalyst if results/guidance surprise positively.
Technical deterioration: price below S1 support with a negatively expanding MACD histogram.
Downside-biased near-term pattern probabilities (1D/1W/1M).
Analyst downgrade to Market Perform with a $5.95 target (materially below current price), citing valuation and lack of material commercialization progress plus guidance uncertainty tied to a contract timing question.
No supportive news flow in the past week to reverse sentiment or provide a fresh catalyst.
Latest quarter: 2025/Q3.
Recent trend: Downward. On 2025-11-12, Northland downgraded QUIK to Market Perform from Outperform and kept the price target at $5.95, citing valuation concerns and waiting for more material commercialization progress amid uncertain contract timing.
Wall Street pros vs cons:
Influential/political trading check: No recent congress trading data available; hedge funds and insiders are neutral with no significant recent trends.